Cambium Bio Limited has released a press release.
Regeneus Announces Institutional Placement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cambium Bio
- Appendix 4C - Quarterly
- Regeneus partners with Defence to treat combat casualties
- Regeneus to be granted key Progenza patent in Europe
- Regeneus Company Update Investor Webcast Presentation
- Half-Year Results and Business Update
Later from Cambium Bio
- Regeneus Market Update
- Grant of ASX Waiver
- Preliminary Final Report
- Notice of Termination of Kyocera Licence
- Regeneus agrees to settle $2m loan
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio